Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $293,017 | 16 | 94.2% |
| Consulting Fee | $15,900 | 3 | 5.1% |
| Travel and Lodging | $1,956 | 5 | 0.6% |
| Food and Beverage | $326.23 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $311,199 | 27 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $123,843 | 6 | Pacira Pharmaceuticals Incorporated ($123,843) |
| 2019 | $187,357 | 21 | Pacira Pharmaceuticals Incorporated ($187,357) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2020 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $39,336.48 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/01/2020 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $16,901.23 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/01/2020 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $16,901.23 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/01/2020 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $16,901.23 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/01/2020 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $16,901.23 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/01/2020 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $16,901.23 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/02/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $16,901.23 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/02/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $16,901.23 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/13/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Consulting Fee | Cash or cash equivalent | $9,975.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/13/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Travel and Lodging | Cash or cash equivalent | $610.60 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/02/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $16,921.52 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/02/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $16,921.52 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/02/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $16,921.52 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/02/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $16,921.52 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/02/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $16,921.52 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/02/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $16,921.52 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/21/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Consulting Fee | Cash or cash equivalent | $5,425.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/21/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Travel and Lodging | Cash or cash equivalent | $553.96 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/21/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Travel and Lodging | Cash or cash equivalent | $544.81 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/21/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/21/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Travel and Lodging | Cash or cash equivalent | $123.30 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/21/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Travel and Lodging | Cash or cash equivalent | $123.30 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/21/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Food and Beverage | Cash or cash equivalent | $30.11 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/02/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $16,921.52 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/02/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $16,921.52 | General |
| Category: PAIN MANAGEMENT | ||||||
About Darin Rentz
Darin Rentz is a Anesthesiology healthcare provider based in Lakewood, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114959533.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Darin Rentz has received a total of $311,199 in payments from pharmaceutical and medical device companies, with $123,843 received in 2020. These payments were reported across 27 transactions from 1 company. The most common payment nature is "Current or prospective ownership or investment interest" ($293,017).
Practice Information
- Specialty Anesthesiology
- Location Lakewood, CO
- Active Since 07/07/2006
- Last Updated 08/01/2012
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1114959533
Products in Payments
- EXPAREL (Drug) $311,199
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Lakewood
Kyong Kim, Do, DO
Anesthesiology — Payments: $25,060
Dr. Tyler Pagel, M.d, M.D
Anesthesiology — Payments: $6,865
Dr. Ben Chang, Md, MD
Anesthesiology — Payments: $4,176
Marsha Ditto, M.d, M.D
Anesthesiology — Payments: $1,607
Kristy Luong, Md, MD
Anesthesiology — Payments: $1,507
Dr. Kirankumar Vyas, M.d, M.D
Anesthesiology — Payments: $939.88